Literature DB >> 2806472

Variations of serum lipoproteins during cell proliferation induced by lead nitrate.

S Dessí1, B Batetta, A Carrucciu, D Pulisci, S Laconi, A M Fadda, C Anchisi, P Pani.   

Abstract

In the present study serum lipoproteins were investigated during cell proliferation induced by a potent mitogen, lead nitrate. A strong decrease in HDL2 and a concomitant increase in HDL3 were observed in lead-treated rats. The recovery of normal lipoprotein pattern took place together with the regression of hyperplastic process. Since a decrease in HDL also occurs under other conditions of cell growth, we hypothesize that a decrease in HDL, mainly in HDL2 subfraction, may represent a generalized phenomenon related to massive cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2806472     DOI: 10.1016/0014-4800(89)90010-5

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  6 in total

1.  The association between occupational lead exposure and serum cholesterol and lipoprotein levels.

Authors:  E Kristal-Boneh; D Coller; P Froom; G Harari; J Ribak
Journal:  Am J Public Health       Date:  1999-07       Impact factor: 9.308

2.  Lipid levels in serum and cancerous tissues of colorectal cancer patients.

Authors:  Xin Zhang; Xian-Wen Zhao; Dong-Bo Liu; Cun-Zhi Han; Li-Li Du; Jie-Xiang Jing; Yan Wang
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

3.  Cell cholesterol esters and high-density lipoprotein plasma levels during liver hyperplasia in choline-fed male and female rats.

Authors:  L Tessitore; B Batetta; B Vizio; M F Mulas; B Marengo; S Dessi
Journal:  Int J Exp Pathol       Date:  2000-08       Impact factor: 1.925

4.  Circulating Lipid- and Inflammation-Based Risk (CLIR) Score: A Promising New Model for Predicting Outcomes in Complete Colorectal Liver Metastases Resection.

Authors:  Long Bai; Xiao-Luan Yan; Yun-Xin Lu; Qi Meng; Yu-Ming Rong; Liu-Fang Ye; Zhi-Zhong Pan; Bao-Cai Xing; De-Shen Wang
Journal:  Ann Surg Oncol       Date:  2022-01-04       Impact factor: 4.339

5.  Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130).

Authors:  S Dessí; B Batetta; C Anchisi; P Pani; P Costelli; L Tessitore; F M Baccino
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

6.  Perturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130).

Authors:  S Dessì; B Batetta; O Spano; G J Bagby; L Tessitore; P Costelli; F M Baccino; P Pani; J M Argilès
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.